Instantaneous
发表于 2025-3-26 22:52:37
T. Kawaguchi,K. Hishida,M. Maedas may account for as much as 30% of interindividual differences in drug disposition and response. An increasing number of drug target polymorphisms have also been linked to differences in drug response. This chapter reviews some examples of the use of pharmacogenetics in clinical practice. Despite t
liaison
发表于 2025-3-27 03:13:23
http://reply.papertrans.cn/19/1884/188315/188315_32.png
explicit
发表于 2025-3-27 07:41:33
http://reply.papertrans.cn/19/1884/188315/188315_33.png
可耕种
发表于 2025-3-27 10:10:26
http://reply.papertrans.cn/19/1884/188315/188315_34.png
龙虾
发表于 2025-3-27 16:59:06
R. J. Adrian,D. F. G. Durao,J. H. Whitelaw no FOPP have yet been approved in the US or European pharmaceutical market. This is because of a lack of registration process for the demonstration of pharmaceutical and therapeutic/clinical equivalence. The production of FOPP is a significant opportunity for patients, managed health care providers
高原
发表于 2025-3-27 18:04:30
http://reply.papertrans.cn/19/1884/188315/188315_36.png
Defraud
发表于 2025-3-27 23:58:53
Microarray Technology Using Proteins, Cells, and Tissues,analysis. This chapter reviews the current status of protein microarray assays and highlights efforts using cells and tissues on microarrays. These ‘other’ microarrays have the potential to yield highly parallel miniaturized assays that will accelerate drug discovery efforts and facilitate understanding of biological complexity.
有节制
发表于 2025-3-28 03:00:23
http://reply.papertrans.cn/19/1884/188315/188315_38.png
无脊椎
发表于 2025-3-28 06:50:06
http://image.papertrans.cn/b/image/188315.jpg
要素
发表于 2025-3-28 13:54:16
https://doi.org/10.1007/978-3-540-45867-8analysis. This chapter reviews the current status of protein microarray assays and highlights efforts using cells and tissues on microarrays. These ‘other’ microarrays have the potential to yield highly parallel miniaturized assays that will accelerate drug discovery efforts and facilitate understanding of biological complexity.